Arginase II inhibitory activity of flavonoid compounds from Scutellaria indica

Archives of Pharmacal Research

Volumn 36, Issue 8, 2013, Pages 922-926

  Kim, Sang Won ^a   Cuong, To Dao ^a   Hung, Tran Manh ^a   Ryoo, Sungwoo ^b   Lee, Jeong Hyung ^b   Min, Byung Sun ^a  

^a Catholic University of Daegu   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Arginase II inhibitory activity; Flavonoid; Labiatae; Scutellaria indica

Indexed keywords

4,5,6,7,8,4' HEXAMETHOXYLFLAVANONE; ARGINASE; ARGINASE II; FLAVONOID; GLUCOPYRANOSIDE; HYDROLASE INHIBITOR; PICEATANNOL 3' BETA DEXTRO GLUCOPYRANOSIDE; PLANT EXTRACT; SCUTELLARIA INDICA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COLUMN CHROMATOGRAPHY; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME INHIBITION; FRACTIONATION; IC 50; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SCUTELLARIA; SCUTELLARIA INDICA;

ANIMALS; ARGINASE; ENZYME INHIBITORS; FLAVONOIDS; MICE; MICE, INBRED C57BL; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; SCUTELLARIA;

EID: 84881311716     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0125-3     Document Type: Article

References (19)

1. Bae, K.H.; B.S. Min, K.L. Park, and B.Z. Ahn. 1994. Cytotoxic flavonoids from Scutellaria indica. Planta Medica 60: 280-281.
2. Barrett, M.W.; W. Klyne, P.M. Scopes, A.C. Fletcher, L.J. Porter, and E. Haslam. 1979. Plant proanthocyanidins. Part 6. Chiroptical studies. Part 95. Circular dichroism of procyanidins. Journal of the Chemical Society Perkin Transactions 1: 2375-2377.
3. Berkowitz, D.E.; R. White, D. Li, K.M. Minhas, A. Cernetich, S. Kim, S. Burke, A.A. Shoukas, D. Nyhan, H.C. Champion, and J.M. Hare. 2003. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108: 2000-2006.
4. Bivalaqua, T.J.; W.J. Hellstrom, P.J. Kadowitz, and H.C. Champion. 2001. Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochemical and Biophysical Research Communications 283: 923-927.
5. Botha, J.J.; D.A. Young, D. Ferreira, and D.G. Roux. 1981. Synthesis of condensed tannins. Part 1. Stereo selective and stereo specific syntheses of optically pure 4-arylflavan-3-ols, and assessment of their absolute stereochemistry at C-4 by means of circular dichroism. Journal of the Chemical Society Perkin Transactions 1: 1213-1245.
6. Chiang Su New Medical College (ed.). (1977) In Dictionary of Chinese Crude Drugs, p. 2303, Shanghai Scientific Technological Publisher, Shanghai.
7. Demougeot, C.; A. Prigent-Tessier, C. Marie, and A. Berthelot. 2005. Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats. Journal of Hypertension 25: 971-978.
8. Ibrahim, A.R.S.; A.M. Galal, M.S. Ahmed, and G.S. Mossac. 2003. O-demethylation and sulfation of 7-methoxylated flavanones by Cunninghamella elegans. Chemical and Pharmaceutical Bulletin 51: 203-206.
9. Johnson, F.K.; R.A. Johnson, K.J. Peyton, and W. Durante. 2005. Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 288: 1057-1062.
10. Li, J.; Y. Ding, X.C. Li, D. Ferreira, S. Khan, T. Smillie, and I.A. Khan. 2009. Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora. Journal of Natural Products 72: 983-987.
11. 13C NMR spectra of the flavone apigenin. Magnetic Resonance in Chemistry 24: 879-882.
12. Miyaichi, Y.; Y. Imoto, T. Tomimori, and C.C. Lin. 1987. Studies on the constituents of Scutellaria species XI. On the flavonoid constituents of the aerial parts of Scutellaria indica L. Chemical and Pharmaceutical Bulletin 35: 3720-3725.
13. Ryoo, S.; D.E. Berkowitz, and H.K. Lim. 2011a. Endothelial arginase II and atherosclerosis. Korean Journal of Anesthesiology 61: 3-11.
14. Ryoo, S.; A. Bhunia, F. Chang, A. Shoukas, D.E. Berkowitz, and L.H. Romer. 2011b. OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling. Atherosclerosis 214: 279-287.
15. Ryoo, S.; G. Gupta, A. Benjo, H.K. Lim, A. Camara, G. Sikka, H.K. Lim, J. Sohi, L. Santhanam, K. Soucy, E. Tuday, E. Baraban, M. Ilies, G. Gerstenblith, D. Nyhan, A. Shoukas, D.W. Christianson, N.J. Alp, H.C. Champion, D. Huso, and D.E. Berkowitz. 2008. Endothelial arginase II: A novel target for the treatment of atherosclerosis. Circulation Research 102: 923-932.
16. Ryoo, S.; C.A. Lemmon, K.G. Soucy, G. Gupta, A.R. White, D. Nyhan, A. Shoukas, L.H. Romer, and D.E. Berkowitz. 2006. Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circulation Research 99: 951-960.
17. Tomimori, T.; Y. Miyaichi, Y. Imoto, H. Kizu, and T. Namba. 1985. Studies on Nepalese crude drugs. V. On the flavonoid constituents of the root of Scutellaria discolor. Chemical and Pharmaceutical Bulletin 33: 4457-4463.
18. White, A.R.; S. Ryoo, D. Li, H.C. Champion, J. Steppan, D. Wang, D. Nyhan, A.A. Shoukas, J.M. Hare, and D.E. Berkowitz. 2006. Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension 47: 245-251.
19. Woo, A.; B.S. Min, and S. Ryoo. 2010. Piceatannol-3′-O-β-d- glucopyranoside as an active component of rhubarb activates endothelial nitric oxide synthase through inhibition of arginase activity. Experimental and Molecular Medicine 42: 524-532.